Stay updated on SB17 vs Stelara in Plaque Psoriasis Clinical Trial
Sign up to get notified when there's something new on the SB17 vs Stelara in Plaque Psoriasis Clinical Trial page.

Latest updates to the SB17 vs Stelara in Plaque Psoriasis Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study content, replacing the study record with an access-denied message and removing visible study details.SummaryDifference17%

- Check19 days agoChange DetectedThe page now displays Revision: v3.7.0, replacing the previous Revision: v3.6.6. This indicates an updated version of the page used for tracking changes, with likely backend or layout updates rather than changes to study information.SummaryDifference0.0%

- Check33 days agoChange DetectedThe page revision has been updated to v3.6.6, indicating a small maintenance update to the ClinicalTrials.gov entry rather than a change to the trial details.SummaryDifference0.0%

- Check54 days agoChange DetectedThe page shows a new revision label, updating from v3.6.4 to v3.6.5.SummaryDifference0.0%

- Check68 days agoChange DetectedThe study location spelling was updated to Zaporizhzhya, Ukraine, replacing Zaporizhzhia, Ukraine. This reflects a transliteration adjustment in the site listing to standardize the location name.SummaryDifference0.1%

- Check97 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.3, signaling a newer build of the page template or content.SummaryDifference0.0%

Stay in the know with updates to SB17 vs Stelara in Plaque Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SB17 vs Stelara in Plaque Psoriasis Clinical Trial page.